Influence of Light Exposure on Cerebral MAO-A in Seasonal Affective Disorder and Healthy Controls Measured by PET

NACompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 3, 2017

Study Completion Date

April 3, 2017

Conditions
Seasonal Affective Disorder
Interventions
OTHER

Light Therapy

One subgroup of SAD patients and healthy controls respectively will receive bright light therapy using an artificial white light source (PhysioLight LD220 by DAVITA®, www.davita.de/shop/lichttherapiegeraete/lichtduschen-tageslicht/physiolight-ld-220.html) with full-spectrum 10.000lux light intensity. The treatment will be applied 30min per day at a distance of about of 50cm, preferably in the morning, during 3 weeks.

OTHER

Placebo Light

The second subgroup of the SAD patients and healthy controls will receive a non-biologically active light source (\<400nm or \>500nm). Here, the lamp will have largely similar shape and size as compared to the therapeutic device, but the fluorescent tube with the high light intensity will be replaced by an ordinary bulb.

Trial Locations (1)

Unknown

Department of Psychiatry and Psychotherapy, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT02582398 - Influence of Light Exposure on Cerebral MAO-A in Seasonal Affective Disorder and Healthy Controls Measured by PET | Biotech Hunter | Biotech Hunter